Mercredi, 16 Octobre 2019
Dernières nouvelles
Principale » Is there Inherent Value in The Chemours Company (NYSE:CC)

Is there Inherent Value in The Chemours Company (NYSE:CC)

13 Décembre 2017

News headlines about Chemours (NYSE:CC) have trended somewhat positive recently, Accern Sentiment Analysis reports. The firm owned 307,551 shares of the specialty chemicals company's stock after selling 49,113 shares during the period.

A number of other large investors have also recently bought and sold shares of CC. Russell Investments Group Ltd. purchased a new stake in Chemours Company (The) during the fourth quarter valued at about $1,853,000. Public Employees Retirement System of OH raised its holdings in Chemours by 306.4% in the second quarter.

Checking out a public company's Earnings per Share (EPS) is a smart way of assessing its profitability. Acrospire Investment Management LLC raised its holdings in Chemours by 3.4% in the 2nd quarter. CAG attains analyst recommendation of 2.20 on scale of 1-5 with week's performance of -0.59%. Victory Capital Management Inc. now owns 657,810 shares of the specialty chemicals company's stock valued at $24,944,000 after buying an additional 489,990 shares during the period. ET AL acquired a new stake in shares of Chemours during the 3rd quarter worth approximately $202,000. Hedge funds and other institutional investors own 75.01% of the company's stock.

CC has been the subject of a number of recent analyst reports. Citigroup Inc. increased their target price on Chemours Company (The) from $62.00 to $63.00 and gave the stock a "buy" rating in a research report on Monday, April 17th. Jefferies Group raised their price target on shares of Chemours to $66.00 and gave the stock a "buy" rating in a report on Monday, December 4th. Finally, Goldman Sachs Group cut shares of Chemours from a "buy" rating to a "neutral" rating and set a $55.00 price target for the company.in a report on Wednesday, December 6th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Meanwhile, the average 12-month price target from Wall Street analysts is now $62.61, this means that the stock is underpriced by 0.687%.

Shares of Chemours Company (NYSE CC) traded up $0.50 during trading hours on Tuesday, reaching $48.14.

Endangered Right Whales Could Become Extinct After a Deadly 2017, Officials Say
The US and Canada officials are believed to be brainstorming on measures to protect the right whales. Recent scientific research has shed some light on why whale deaths have encountered an upward tick.

Over the past 50 days, The Chemours Company stock was -16.22% off of the high and 8.06% removed from the low. TIAA CREF Investment Management LLC now owns 1,789,112 shares of the specialty chemicals company's stock valued at $67,843,000 after acquiring an additional 999,380 shares during the last quarter. The Earnings Yield for The Chemours Company NYSE:CC is 0.071835. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.01 by $0.11. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. Chemours had a return on equity of 116.80% and a net margin of 4.86%. During the same quarter previous year, the company posted $0.61 earnings per share.

The firm has price volatility of 4.66% for a week and 3.89% for a month. Stockholders of record on Wednesday, May 17th will be given a $0.03 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.41%. This is an increase from Chemours's previous quarterly dividend of $0.03. Chemours's dividend payout ratio is now 8.28%.

Chemours declared that its board has authorized a share repurchase plan on Friday, December 1st that permits the company to repurchase $500.00 million in shares. Smithfield Trust Co. now owns 4,791 shares of the specialty chemicals company's stock worth $182,000 after buying an additional 4,020 shares during the last quarter. Accern also assigned headlines about the specialty chemicals company an impact score of 46.0874845165437 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

In other news, SVP David C. Shelton sold 13,397 shares of the company's stock in a transaction dated Tuesday, October 10th. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider E Bryan Snell sold 11,878 shares of the firm's stock in a transaction that occurred on Monday, November 6th. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows "Sell" signal.